Organisation
The Senior Office holders of the MSG during 2020 were as follows:
Senior Office
Dr Gary Yarwood
Chairman
Dr James Chandler
Lead Governance Partner
Mr Michael Blundell
Lead Finance Partner
Directorate Chairs
Dr Hamish Duncan
Adult Medicine
Dr Steve Evans
Adult Medicine
Dr Graham Beck
Anaesthetics
Mr Thomas Fysh
Surgical
Mr Frank Hopkins
Women & Child Health
Throughout 2020, the MSG had 51 approved positions (the newly approved position for Neurology will take this to 52) with 51 Consultants across four directorates. The specialties covered are as follows:
Adult Medicine 13 Consultants
- Cardiology
- Gastroenterology
- Oncology
- Diabetes/Endocrinology
- Geriatrics
- Nephrology
- Respiratory
Anaesthetics 11 Consultants
- Anaesthetics
- Intensive Care
- Chronic Pain
Surgery 15 Consultants
- General Surgery
- Breast Surgery
- Ear, Nose & Throat
- Ophthalmology
- Orthopaedics
- Urology
Women & Child Health 12 Consultants
- Obstetrics & Gynaecology
- Paediatrics
The income for the MSG comes primarily from the secondary healthcare contract (90%). The balance is from private earnings. Due to Covid-19 restrictions, there was an impact on the services that MSG were able to provide during the lockdown period, which impacted on our income. We were able to reduce our expenses in some areas, however these savings have been offset by an increase in other areas (e.g. Insurance and property). Total costs to the business therefore increased by 0.6% compared to 2019.